Finds nanobubbles reduce oxidative stress by inhibiting singlet oxygen activity, suggesting a novel antioxidant approach.
Abnormal accumulation of reactive oxygen species (ROS) induces oxidative stress, a central pathological factor in many human diseases. Traditionally, antioxidants are suggested to relieve oxidative stress in the body; however, their efficacy is limited by poor stability in vivo and inadequate tissue targeting in clinical practice. Therefore, there is a great need for an effective, safe, biocompatible, and environmentally friendly antioxidant strategy to reduce damage caused by oxidative stress. Previous work has demonstrated that nanobubbles (NBs) can regulate hydroxyl radical ( • OH)-mediated redox reactions. However, it remains unclear whether NBs can exert similar regulatory control on singlet oxygen ( 1 O 2 ), and the molecular mechanisms that control this interaction need to be elucidated. In this work, we employed photodynamic reactions to generate 1 O 2 and systematically investigated the effects of NBs of different particle sizes and different encapsulated gas compositions (N 2 or O 2 ) on 1 O 2 -mediated oxidation of selective fluorescent probes. Our findings indicate that ultrasmall NBs exhibit remarkable antioxidant activity across all test systems and that even NBs prepared with O 2, a gas that typically enhances ROS-driven oxidation, inhibit 1 O 2 -mediated substrate oxidation. These insights establish a basic framework for the rational design of NB-based antioxidant platforms, which hold significant promise for applications in biomedical antioxidant therapy, material protection, and food preservation.
No takes yet. Share an insight, caveat, or question.
Tian et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: